Skip to main content
. Author manuscript; available in PMC: 2019 Mar 27.
Published in final edited form as: AIDS. 2018 Mar 27;32(6):767–771. doi: 10.1097/QAD.0000000000001751

Table 1.

Associations of recent stimulant use with intestinal barrier integrity and monocyte activation (N = 84).

Stimulants Tox+ (n = 51) Stimulants Tox− (n = 33) Cohen’s d p-value
M (SD) M (SD)
sCD14 (ng/ml) 2,087.28 (543.51) 1,800.73 (351.28) 0.63 0.009
sCD163 (Log10) 2.82 (0.19) 2.79 (0.20) 0.15 0.440
iFABP (Log10) 3.51 (0.25) 3.56 (0.17) −0.23 0.343

sCD14 = soluble CD14; sCD163 = soluble CD163; iFABP = intestinal fatty acid binding protein; Tox+ = reactive urine toxicology results for stimulants at screening or baseline; Tox− = non-reactive urine toxicology results for stimlants at screening and baseline